{
    "clinical_study": {
        "@rank": "35106", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "An identical appearing placebo will be administered."
            }, 
            {
                "arm_group_label": "THR-184 Dose 1", 
                "arm_group_type": "Experimental", 
                "description": "THR-184 initial low dose"
            }, 
            {
                "arm_group_label": "THR-184 Dose 2", 
                "arm_group_type": "Experimental", 
                "description": "THR-184 initial middle dose"
            }, 
            {
                "arm_group_label": "THR-184 Dose 3", 
                "arm_group_type": "Experimental", 
                "description": "THR-184 initial high dose"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether THR-184 when administered around the time\n      of cardiac surgery that requires cardiopulmonary bypass can prevent or ameliorate the\n      development of acute kidney injury."
        }, 
        "brief_title": "A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Kidney Injury", 
        "condition_browse": {
            "mesh_term": [
                "Acute Kidney Injury", 
                "Wounds and Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "The study has been designed to include patients scheduled for cardiac surgery who are\n      considered at increased risk for developing CSA-AKI. The eligibility criteria are intended\n      to enrich the study population with such patients.\n\n      Stage 1 will consist of 140 patients randomized in a 1:1:1:1 ratio (approximately 35\n      patients per treatment arm) to Placebo or to one of three (3) THR-184 dose arms:\n\n        -  initial pre-surgery low dose of THR-184 by three (3) post-surgery doses of at the low\n           dose, or\n\n        -  initial pre-surgery middle dose of THR-184 followed by three (3) post-surgery doses at\n           the low dose, or\n\n        -  initial pre-surgery high dose of THR-184  followed by three (3) post-surgery doses at\n           the low dose\n\n      Stage 2 will consist of approximately 210 patients randomized in a 1:1 ratio (approximately\n      105 patients per treatment arm) to Placebo or to a dose selected from one of the three (3)\n      THR-184 dose arms tested in Stage 1.\n\n      Study treatment (THR-184 or placebo) will consist of one 60-minute IV infusion administered\n      prior to surgery, followed by a 60-minute  IV infusion  administered, beginning in the early\n      post-operative period, and followed by two (2) additional 60-minute  IV infusions\n      administered,  on consecutive  days post-cardiac surgery.\n\n      The primary endpoint for the evaluation of efficacy in patients receiving THR-184, as\n      compared to patients receiving Placebo, will be the proportion of patients developing\n      CSA-AKI as measured by the Kidney Disease Improving Global Outcomes (KDIGO) criteria, as\n      follows:\n\n        -  Increase in Serum creatinine (SCr) by \u22650.3 mg/dl (>26.5 \u00b5mol/l) within 48 hours\n           post-surgery; or\n\n        -  Increase in SCr to \u22651.5 times a baseline which has been measured in the previous 7\n           days; or\n\n        -  Urine volume <0.5 ml/kg/h for 6 hours post-operatively\n\n      If at least one of these measures is present by the 7 day assessment, a patient will be\n      considered to have developed CSA-AKI."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female and >18 years of age.\n\n          -  Scheduled for a non-emergent procedure requiring CPB, to include:\n\n               -  coronary artery bypass graft (CABG) alone;\n\n               -  aortic valve replacement or repair alone, with or without aortic root repair;\n\n               -  mitral, tricuspid, or pulmonic valve replacement or repair alone;\n\n               -  simultaneous replacement of several cardiac valves;\n\n               -  CABG with aortic, mitral, tricuspid, or pulmonic valve replacement or repair;\n\n               -  CABG with combined cardiac valve replacement or repair.\n\n          -  Have the following risk factors for CSA-AKI:\n\n               -  eGFR \u2265 20 and < 30 ml/min/1.73m2 OR\n\n               -  eGFR \u2265 30 and < 60 ml/min/1.73m2 and ONE of the following additional risk\n                  factors (other than age \u2265 75 years) OR\n\n               -  eGFR \u2265 60 ml/min/1.73m2 and TWO of the following additional risk factors\n\n        Additional Risk Factors:\n\n          -  Age \u2265 75 years;\n\n          -  Combined valve & coronary surgery;\n\n          -  Previous cardiac surgery with sternotomy;\n\n          -  Documented NYHA Class III or IV within 1 year prior to surgery;\n\n          -  Left ventricular ejection fraction (LVEF) \u2264 35% by invasive or noninvasive diagnostic\n             cardiac imaging - echocardiography, nuclear imaging, computed tomography, magnetic\n             resonance imaging or angiography performed within 90 days prior to surgery.  (If LVEF\n             \u2264 35% by any invasive or noninvasive imaging procedure, patient meets the risk\n             factor.)\n\n          -  Insulin-requiring diabetes;\n\n          -  Non-insulin-requiring diabetes and the presence of \u2265+2 proteinuria on urinalysis\n             (medical history or dipstick);\n\n          -  Preoperative anemia (hemoglobin <11g/dl for men and women).\n\n        Exclusion Criteria:\n\n        If any of the following criteria apply prior to surgery, the patient will be excluded from\n        the study:\n\n          -  Age > 85 years;\n\n          -  Weight >174 kg or 383 lbs;\n\n          -  The presence of AKI (KDIGO criteria) at the time of screening ;\n\n          -  Surgery to be performed without CPB;\n\n          -  Surgery to be performed under conditions of circulatory arrest or hypothermia with\n             rectal temperature < 28\u00b0Celsius (82.4\u00b0 Fahrenheit);\n\n          -  eGFR (MDRD) <20 ml/min/1.73m2;\n\n          -  Surgery for aortic dissection;\n\n          -  Surgery to correct a major congenital heart defect (e.g., Tetralogy of Fallot,\n             transposition of the great vessels, single ventricle, Ebstein's anomaly. Bicuspid\n             aortic valve is not to be considered a congenital heart defect.);\n\n          -  Prior organ transplantation;\n\n          -  Dialysis-dependence;\n\n          -  Administration of iodinated contrast media within 24 hours prior to cardiac surgery;\n\n          -  If received contrast media prior to 24 hours and have AKI as defined by KDIGO\n             criteria;\n\n          -  Cardiogenic shock or haemodynamic instability within the 24 hours prior to surgery,\n             including the anesthesia induction period; as defined by a systolic BP <80 mm Hg and\n             pulse >120 beats per minute (bpm) and requirement for inotropes or vasopressors or\n             other mechanical devices such as intra-aortic balloon counter-pulsation (IABP);\n\n          -  Requirement for any of the following within seven (7) days prior to cardiac surgery:\n\n               -  defibrillator or permanent pacemaker,\n\n               -  mechanical ventilation,\n\n               -  intra-aortic balloon counter-pulsation (IABP),\n\n               -  left ventricular assist device (LVAD),\n\n               -  other forms of mechanical circulatory support (MCS);\n\n          -  Cardiopulmonary resuscitation within 14 days prior to cardiac surgery;\n\n          -  Known history of cancer within the past 5 years, except for carcinoma in situ of the\n             cervix or adequately treated basal cell carcinoma of the skin;\n\n          -  Known or suspected sepsis at time of screening;\n\n          -  Known or suspected glomerulonephritis or interstitial nephritis at time of screening;\n\n          -  Confirmed or treated endocarditis within previous 30 days prior to cardiac surgery;\n\n          -  Other current active infection requiring antibiotic treatment;\n\n          -  Patients with known active human immunodeficiency virus infection;\n\n          -  Documented history of HIV antibodies;\n\n          -  Patients with known active Hepatitis B (HBV) or Hepatitis C (HCV) infection;\n\n          -  Documented history of HCV antibodies;\n\n          -  Documented history of HBV antigens;\n\n          -  Patients on immunosuppressant drugs or prednisone over the dose of 20 mg per day;\n\n          -  Inadequate hepatic function, defined as total bilirubin or alanine aminotransferase\n             (ALT) or aspartate aminotransferase (AST) > 2 times the upper limit of normal (ULN)\n             at time of screening or Child's Pugh Class C liver disease ( see appendix 6) or\n             higher;\n\n          -  Any congenital coagulation disorder;\n\n          -  Pregnancy or lactation;\n\n          -  If patient has \"Do Not Resuscitate\" (DNR) status;\n\n          -  Known hypersensitivity to the study drug or any of its excipients;\n\n          -  Treatment with an investigational drug or participation in an interventional trial\n             within 60 days prior to 1st dose of study drug;\n\n          -  In the opinion of the investigator any disease processes or confounding variables\n             that would inappropriately alter the outcome of the study;\n\n          -  Inability to comply with the requirements of the study protocol."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "350", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01830920", 
            "org_study_id": "A-003", 
            "secondary_id": "2741202"
        }, 
        "intervention": {
            "arm_group_label": [
                "THR-184 Dose 1", 
                "THR-184 Dose 2", 
                "THR-184 Dose 3"
            ], 
            "description": "The initial dose will vary.", 
            "intervention_name": "THR-184", 
            "intervention_type": "Drug", 
            "other_name": "Synthetic oligopeptide"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Acute Kidney Injury", 
            "AKI", 
            "Cardiac surgery"
        ], 
        "lastchanged_date": "January 27, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90033"
                    }, 
                    "name": "University of Southern California"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stanford", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94305"
                    }, 
                    "name": "Stanford University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torrance", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90503"
                    }, 
                    "name": "Harbor - University of California Los Angeles Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Danbury", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06810"
                    }, 
                    "name": "Danbury Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60637"
                    }, 
                    "name": "University of Chicago"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oak Lawn", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60453"
                    }, 
                    "name": "Advocate Christ Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Petoskey", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "49770"
                    }, 
                    "name": "Cardiac and Vascular Research Center of Northern Michigan"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paterson", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07503"
                    }, 
                    "name": "St. Joseph's Regional Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albany", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "12208"
                    }, 
                    "name": "St. Peter's Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10032"
                    }, 
                    "name": "Columbia University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27710"
                    }, 
                    "name": "Duke University Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27710"
                    }, 
                    "name": "Durham VA Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43210"
                    }, 
                    "name": "The Ohio State University Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chattanooga", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37404"
                    }, 
                    "name": "Erlanger Health System"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75226"
                    }, 
                    "name": "Baylor University Medical Center, Soltero Cardiovascular Research Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "University of Texas, Houston"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23225"
                    }, 
                    "name": "Cardiothoracic Surgical Associates"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St-John", 
                        "country": "Canada", 
                        "state": "New Brunswick", 
                        "zip": "E2L4L2"
                    }, 
                    "name": "St-John Regional Hospital Facility"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ottawa", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "K1Y 4W7"
                    }, 
                    "name": "University of Ottawa Heart Institute"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montr\u00e9al", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "H1T 1C8"
                    }, 
                    "name": "Institut de Cardiologie de Montr\u00e9al"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montr\u00e9al", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "H4J 1C5"
                    }, 
                    "name": "Sacre C\u0153ur Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montr\u00e9al", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "H3A 1A1"
                    }, 
                    "name": "MUHC - Royal Victoria Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Qu\u00e9bec", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "G1V 4G5"
                    }, 
                    "name": "Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada"
            ]
        }, 
        "number_of_arms": "4", 
        "official_title": "A Multi-Center, Parallel-Group, Randomized, Double Blind, Adaptive Study Investigating the Safety and Efficacy of THR-184 in Patients at Increased Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)", 
        "other_outcome": {
            "measure": "All-cause mortality", 
            "safety_issue": "Yes", 
            "time_frame": "60 days"
        }, 
        "overall_contact": {
            "email": "bjohnston@ctifacts.com", 
            "last_name": "Brian Johnston", 
            "phone": "(513) 598-9290"
        }, 
        "overall_official": {
            "affiliation": "Thrasos Innovation, Inc.", 
            "last_name": "Andreas Orfanos, MBBCh", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Canada: Health Canada"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Incidence of acute kidney injury (AK)", 
            "safety_issue": "Yes", 
            "time_frame": "7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01830920"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Maximum change from baseline in serum creatinine", 
            "safety_issue": "Yes", 
            "time_frame": "7 days"
        }, 
        "source": "Thrasos Innovation, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Thrasos Innovation, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}